By Michael Gwarisa The World Health Organization (WHO) has projected an increasing burden in disabling hearing loss in Africa at the back limited capacity to handle hearing loss ailments, an ill-equipped workforce amongst a host of other factors. Data from 43 African countries show that while 36 countries provide EHC services at the tertiary level,
Read MoreBy Staff Reporter Lima, Peru – The Population Council, an international nonprofit research organization, announced today at HIVR4P 2024, the 5th HIV Research for Prevention Conference, the results of a phase I open-label randomized crossover relative bioavailability trial (IPM 054). The trial found that a 3-month dapivirine vaginal ring delivers the active antiretroviral drug, dapivirine,
Read MoreBy Michael Gwarisa The World Health Organization (WHO) has listed the first mpox in vitro diagnostic (IVD) under its Emergency Use Listing (EUL) procedure, an important step in improving global access to mpox testing. The approval for emergency use of the Alinity m MPXV assay, manufactured by Abbott Molecular Inc., will be pivotal in expanding
Read MoreBy Staff Reporter The Society for AIDS in Africa (SAA) is delighted to announce that Ghana has been selected as the host country for the 23rd edition of the International Conference on AIDS and STIs in Africa (ICASA), which will take place in from 3rd to 8th December 2025 at the Accra International Conference Centre.
Read MoreBy Michael Gwarisa The Africa Centres for Disease Control and Prevention (Africa CDC) has announced the postponement of the 2024 Conference on Public Health in Africa (CPHIA), which was originally set to take place in Morocco from 26 to 29 November 2024. In a statement, Dr. Jean Kaseya, the Africa CDC Director General said the
Read MoreThe United States, through USAID, completed the delivery of 50,000 doses of the JYNNEOS mpox vaccine to the Government of the Democratic Republic of the Congo (DRC) to support its efforts to respond to the ongoing outbreak of clade I mpox. Speaking on the development,United States Agency for International Development Spokesperson, Benjamin Suarato said the
Read MoreKINSHASA – In a significant step to strengthen and accelerate the response to the ongoing the mpox outbreak, the Africa Centres for Disease Control and Prevention (Africa CDC) and World Health Organization (WHO) today launched a joint continental response plan for Africa to support countries’ efforts to curb the spread of the virus, save and protect
Read MoreBy Michael Gwarisa The Africa Centres for Disease Control and Prevention (Africa CDC) and United Nations Children’s Fund (UNICEF) are pleased to announce the arrival of the first shipment of 99,100 doses of JYNNEOS mpox vaccine to the Democratic Republic of Congo (DRC). The shipment is expected to launch a critical vaccination campaign aimed at
Read MoreWhile some patients experience adverse drug reactions (ADRs) when taking medicines, others do not, and in some cases, others do not receive therapeutic benefits from treatment regardless of dosage. One reason for this inter-individual variation in response is differences in genes that code for proteins important in drug response. This has given rise to the
Read MoreBy Staff Reporter UNICEF has announced that it has issued an emergency tender for the procurement of mpox vaccines. Vaccines can play a critical role in containing the mpox outbreak which was declared a public health emergency by both the Africa Centres for Disease Control and Prevention (Africa CDC) and the World Health Organization (WHO).
Read More